Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

Med Vision Secures Series A+ Funding to Expand Digital Therapy Portfolio

January 25, 2025
CompanyDrug

Kexing Pharmaceutical Initiates Phase I Trial for IFN-Alpha-1b Inhalation Solution

February 12, 2025
CompanyDeals

Bioantibody Bio Raises RMB 100 Million in Series A Funding Round

January 25, 2025
CompanyDeals

Meihua Partners with Getein Biotech to Manufacture COVID-19 Antigen Tests

January 25, 2025
CompanyDrug

CSPC’s Cleviprex Approved for Clinical Study by China’s NMPA

January 25, 2025
Policy / Regulatory

China’s Dental Implant VBP Tender Results in Significant Price Cuts

January 25, 2025
CompanyDrug

Takeda’s Mobocertinib Approved in China for EGFR Exon20ins NSCLC

January 25, 2025
CompanyDeals

MediTrust Health Secures Series C+ Funding with HSBC as Strategic Investor

January 25, 2025
CompanyDrug

Kelun-Biotech’s SKB264 Approved for Phase II Study in EGFR-Mutant NSCLC

January 25, 2025
Company

BeiGene Outlines Global R&D Strategy at J.P. Morgan Healthcare Summit

January 25, 2025
CompanyDeals

Evopoint Biosciences Licenses SOS1 Inhibitor to METiS Therapeutics

January 25, 2025
CompanyDrug

Pfizer’s Nurtec ODT Launches in China via Hainan’s Bo’Ao Lecheng Zone

January 25, 2025
1 2 … 9 10 11 12 13 … 19 20
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up